Found: 24
Select item for more details and to access through your institution.
Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events.
- Published in:
- Cancer Reports, 2023, v. 6, n. 1, p. 1, doi. 10.1002/cnr2.1627
- By:
- Publication type:
- Article
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 346, doi. 10.3390/curroncol28010038
- By:
- Publication type:
- Article
Post-thaw viability of cryopreserved peripheral blood stem cells ( PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 6, p. 942, doi. 10.1111/bjh.14160
- By:
- Publication type:
- Article
Clinical impact of primary tumour <sup>123</sup>ImIBG response to induction chemotherapy in children with high-risk neuroblastoma.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 1, p. 253, doi. 10.1007/s10147-021-02039-y
- By:
- Publication type:
- Article
Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2485, doi. 10.1007/s00262-022-03159-8
- By:
- Publication type:
- Article
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2985, doi. 10.3390/cancers14122985
- By:
- Publication type:
- Article
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience.
- Published in:
- Paediatrics & Child Health (1205-7088), 2023, v. 28, n. 7, p. 399, doi. 10.1093/pch/pxac122
- By:
- Publication type:
- Article
Precision oncology for children: A primer for paediatricians.
- Published in:
- Paediatrics & Child Health (1205-7088), 2023, v. 28, n. 5, p. 278, doi. 10.1093/pch/pxac123
- By:
- Publication type:
- Article
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7033
- By:
- Publication type:
- Article
Short- and Long-term Mortality Risk After Acute Pulmonary Embolism.
- Published in:
- Current Cardiology Reports, 2018, v. 20, n. 12, p. 1, doi. 10.1007/s11886-018-1084-6
- By:
- Publication type:
- Article
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 5, p. 1, doi. 10.1002/pbc.30217
- By:
- Publication type:
- Article
Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real‐world case series.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29633
- By:
- Publication type:
- Article
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high‐risk neuroblastoma: An International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28794
- By:
- Publication type:
- Article
Phase I dose-finding study for melatonin in pediatric oncology patients with relapsed solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The challenge of defining "ultra-high-risk" neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 1, p. 128, doi. 10.1002/pbc.24656
- By:
- Publication type:
- Article
Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis.
- Published in:
- Annals of Otology, Rhinology & Laryngology, 2024, v. 133, n. 1, p. 119, doi. 10.1177/00034894231184942
- By:
- Publication type:
- Article
Inflammation: What role in pediatric cancer?
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 5, p. 659, doi. 10.1002/pbc.24008
- By:
- Publication type:
- Article
Clinical and pathological features of paediatric malignant rhabdoid tumours.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 1, p. 29, doi. 10.1002/pbc.22231
- By:
- Publication type:
- Article
Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline SMARCA4 and EZH2 variants.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2023, v. 9, n. 4, p. 1, doi. 10.1101/mcs.a006286
- By:
- Publication type:
- Article